Eyesight and red wine, the winning alliance to combat cataracts

Vista e vino rosso, l’alleanza vincente per contrastare la cataratta

Updated and contextualized version of an article originally published on April 2, 2021
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.


Authors

  • Dr. A. Colonnese – Nutrition biologist
  • Roberto Panzironi –Independent researcher 

Note editoriali

  • First publication: April 2, 2021
  • Last update: April 18, 2026
  • Version: 2026 narrative revision  

Editorial note: This article was previously published and has been updated according to scientific and informative criteria for clarity and source verification. The content is for informational purposes only and does not replace medical advice. For personalized advice, it is recommended to consult a healthcare professional.

IN BRIEF

  • Observational studies on large cohorts show an association between moderate alcohol consumption (especially wine) and a lower risk of cataract surgery, but do not prove causality.
  • Phenolic compounds in red wine, such as resveratrol and other polyphenols, have demonstrated antioxidant activity in cellular and animal models, and some metabolites have been detected in human ocular tissues.
  • The evidence is consistent with biological plausibility (reduction of oxidative stress), but observational studies can be influenced by confounding factors and do not clarify the effects of dose or type of beverage.
  • For ocular health, it is more prudent to focus on overall habits: a diet rich in antioxidants, control of diabetes and smoking, and regular eye exams.

Abstract: what does science say?

The central question is whether and to what extent red wine consumption is associated with a lower risk of developing severe cataracts or undergoing cataract surgery. Observational data collected in large British cohorts show that low-to-moderate alcohol consumption, particularly wine, is linked to a relative reduction in the risk of undergoing cataract surgery compared to abstainers. There is biological plausibility: polyphenols present in grapes and red wine exert antioxidant activity in lens cells, and some metabolites have been measured in human ocular tissues. However, the results come from observational studies and reviews that report variable findings; therefore, a definitive causal relationship cannot be stated. The relationship depends on quantity, frequency, type of beverage, and individual health context; at the same time, excessive alcohol carries known systemic risks that must be considered. This update integrates epidemiological evidence and biological mechanisms, and highlights methodological limitations that require further controlled studies and clinical evaluations.

Main section

What is a cataract and why is it of interest

Cataract is the progressive clouding of the lens that reduces the quality of the image on the retina. It is one of the main causes of age-related vision loss and is often corrected with surgery when symptoms interfere with daily life. The process is largely linked to damage from oxidative stress, protein aggregation, and post-translational modifications of lens proteins. Preventive strategies studied include general health measures (glycemic control, not smoking, sun protection) and attention to nutrients and antioxidants in the diet.

Main epidemiological evidence

Two large analyses conducted on British cohorts (EPIC-Norfolk and UK Biobank) reported that low-to-moderate alcohol consumption, and particularly wine consumption, was associated with a lower risk of undergoing cataract surgery compared to abstainers; in subgroups, a relative risk reduction was observed (e.g., ~23% in EPIC-Norfolk and ~14% in UK Biobank in categories with higher wine consumption compared to non-drinkers). These results come from observational analyses that adjusted for various confounding factors, but do not completely eliminate the possibility of residual confounding [1].

What meta-analyses say

Meta-analyses published to date show conflicting results: some find no net effect, others suggest modest reductions in risk in moderate drinkers compared to non-drinkers, while excessive consumption is more frequently associated with adverse outcomes. These differences depend on the type of studies included, the definitions of consumption, and the outcome measurement systems (presence of lens opacity vs. surgical intervention) [2][3].

Plausible biological mechanisms

From a biological perspective, polyphenols present in red wine (resveratrol, anthocyanins, catechins, and others) exert antioxidant activity and modulate cellular pathways related to oxidative stress, inflammation, and apoptosis in ocular cells. Preclinical studies and reviews indicate that resveratrol and other polyphenols can increase the expression of antioxidant enzymes and reduce H2O2-induced damage in lens epithelial cells, suggesting a plausible mechanistic basis for a protective effect [4][5][6].

Evidence of bioavailability

The bioavailability of polyphenols after ingestion is complex: many compounds are rapidly metabolized. However, a study on human ocular tissues detected resveratrol metabolites in the eye after oral administration, indicating that active metabolites can reach the ocular environment and thus exert potential local effects [4].

Complementary experimental evidence

Research in animal models and ex vivo human tissues shows that some polyphenols (e.g., rosmarinic acid, pterostilbene) can delay lens opacification or reduce protein aggregation in experimental preparations, offering further support for biological plausibility but not replacing clinical evidence in humans [7][8].

What it means in practice

The available information must be interpreted with caution. Observational evidence indicates a possible association between moderate wine consumption (especially red wine) and a lower risk of cataract surgery, but does not prove that wine causes the risk reduction. Therefore, it is not correct to recommend starting wine consumption solely to protect vision. Those who already consume wine at moderate levels and without medical contraindications can consider these results as part of a broader picture of healthy habits, but must also evaluate the known risks of alcohol, such as an increased risk of certain cancers and cardiovascular or metabolic problems in some circumstances.

Practical measures with stronger evidence to reduce the risk of cataracts include: diabetes control, avoiding smoking, UV protection (filtered glasses), a diet rich in fruits and vegetables, and regular eye follow-up. The intake of polyphenol-rich foods (berries, grapes, tea, vegetables) is a recognized nutritional choice and does not carry the same risks as alcohol.

KEY POINTS TO REMEMBER

  • Observed association: studies on large cohorts show a correlation between low-to-moderate wine consumption and a relative reduction in the risk of surgical cataracts, but correlation does not imply causality [1].
  • Biological plausibility: wine polyphenols have antioxidant effects and can protect lens cells in experimental models [5][6].
  • Bioavailability: resveratrol metabolites have been detected in human ocular tissues after oral intake, but the concentration and clinical effect remain uncertain [4].
  • Alcohol risks: excessive alcohol carries systemic dangers; possible ocular benefits do not justify alcohol intake for those who do not already consume it.
  • The most prudent approach to cataract prevention is multifactorial: control of known risk factors, a varied diet rich in antioxidants, and regular eye screening.

Limitations of the evidence

It is essential to distinguish between types of studies. Observational studies (cohorts, case-control) can identify associations but do not prove causality: they can be influenced by known confounders (e.g., socioeconomic status, overall diet, smoking, access to care) or by variability in exposure measurement (self-reporting of consumption). Some meta-analyses detect heterogeneity among studies due to definitions of consumption, outcomes, and follow-up [2][3].

Methodological limitations include: imprecise measurement of consumption (frequency vs. quantity), poor representativeness of heavy drinkers in cohorts, different definitions of outcomes (opacity vs. surgery), and the possibility of selection bias. Preclinical evidence suggests mechanisms but does not guarantee clinical effects at the population level. Well-controlled prospective studies and, where possible, intervention studies are needed, but these face ethical and practical limitations in using alcohol as an experimental treatment.

Editorial conclusion

Current evidence suggests that low-to-moderate wine consumption, especially red wine, is associated with a relative reduction in the risk of cataract surgery in some large observational studies. This observation is consistent with the biological plausibility offered by polyphenols (particularly resveratrol and related compounds) which show antioxidant activity in cellular and animal models and whose presence has been demonstrated in the form of metabolites in human ocular tissues. However, given the observational nature of the main evidence and the known risks of alcohol, wine consumption cannot be recommended as a preventive strategy for cataracts. The most solid choices for protecting vision remain controlling known risk factors, protecting the eyes from UV exposure, maintaining a diet rich in vegetables and fruits, and undergoing regular eye exams. Further studies, particularly with repeated measurements of exposure, biomarker studies, and safe experimental approaches, are needed to clarify whether there is a causal effect and to define potentially favorable doses and conditions.

Editorial note

Article updated from a previous version. The changes follow criteria of scientific accuracy, transparency of sources, and institutional informative language. The article is for informational purposes and does not replace personalized clinical advice. For health matters, consult your doctor or trusted specialist.

SCIENTIFIC RESEARCH

  1. Chua SYL, Luben RN, Hayat S, Broadway DC, Khaw KT, Warwick A, Britten A, Day AC, Strouthidis N, Patel PJ, Khaw PT, Foster PJ, Khawaja AP; UK Biobank Eye and Vision Consortium. Alcohol Consumption and Incident Cataract Surgery in Two Large UK Cohorts. Ophthalmology. 2021;128(6):837–847. https://doi.org/10.1016/j.ophtha.2021.02.007
  2. Gong Y, Feng K, Yan N, Xu Y, Pan CW. Different amounts of alcohol consumption and cataract: a meta-analysis. Optom Vis Sci. 2015 Apr;92(4):471–479. https://doi.org/10.1097/OPX.0000000000000558
  3. Shi K, Zhang H, et al. Alcohol intake and the risk of age-related cataracts: a meta-analysis of prospective cohort studies. PLoS One. 2014;9(10):e107820. https://doi.org/10.1371/journal.pone.0107820
  4. Tong Z, et al. Tissue Distribution of trans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes. J Ophthalmol. 2017;2017:4052094. https://doi.org/10.1155/2017/4052094
  5. Varela-Nieto I, et al. New highlights of resveratrol: a review of properties against ocular diseases. Int J Mol Sci. 2021;22(3):1295. https://doi.org/10.3390/ijms22031295
  6. Giordano F, Galderisi U. A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance. Biomed Pharmacother. 2016;84:203–212. https://doi.org/10.1016/j.biopha.2016.11.141
  7. Sanecka A, et al. Rosmarinic Acid Restores Complete Transparency of Sonicated Human Cataract Ex Vivo and Delays Cataract Formation In Vivo. Sci Rep. 2018;8:9341. https://doi.org/10.1038/s41598-018-27516-9
  8. Chang KC, et al. Blueberry Component Pterostilbene Protects Corneal Epithelial Cells from Inflammation via Anti‑oxidative Pathway. Sci Rep. 2016;6:19408. https://doi.org/10.1038/srep19408

Note: For details on methodological aspects and limitations of each study, please refer to the individual documents cited via DOI.